Foamix Pharmaceuticals Ltd. Deferred Tax Assets, Other
Foamix Pharmaceuticals Ltd. had Deferred Tax Assets, Other of $225.00 thousand as of 2019-12-31, per its 10-K filed 2020-03-12.
Discontinued › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsOther · last filed 2020-03-12
- 2019-12-31: Deferred Tax Assets, Other $225.00K.
- 2018-12-31: Deferred Tax Assets, Other $164.00K.
- 2017-12-31: Deferred Tax Assets, Other $175.00K; Deferred Tax Assets, Other as first filed $608.00K.
- 2016-12-31: Deferred Tax Assets, Other $332.00K.
| Period end | Deferred Tax Assets, Other | Deferred Tax Assets, Other as first filed |
|---|---|---|
| 2019-12-31 | $225.00K 10-K · filed 2020-03-12 | |
| 2018-12-31 | $164.00K 10-K · filed 2020-03-12 | |
| 2017-12-31 | $175.00K 10-K · filed 2019-02-28 | $608.00K 10-K · filed 2018-02-27 |
| 2016-12-31 | $332.00K 10-K · filed 2018-03-01 | |
| 2015-12-31 | $299.00K 20-F · filed 2017-02-21 | |
| 2014-12-31 | $101.00K 20-F · filed 2016-03-02 | |
| 2013-12-31 | $31.00K 20-F · filed 2015-03-17 |